Try our Advanced Search for more refined results

EU Eyeing Opening Markets For Biosimilar, Generic Drugs

By Kevin Penton (January 18, 2019, 11:42 PM EST) -- The European Union is developing a draft regulation that would allow continent-based makers of generic and biosimilar drugs to manufacture their versions of protected drugs for exportation to foreign markets where the protections don't exist or have expired, the European Council has announced....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!